Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, will present a ...

Scientists identify mutation patterns in healthy stomach lining, offering new insights into the earliest steps of cancer ...

Researchers at City of Hope have found that cell mutations are necessary but not always sufficient for tumors to form.

Johnson & Johnson announced results for the “gold standard endpoint in cancer treatment” of overall survival from the Phase 3 ...

A study in the journal The Lancet found that early-onset colorectal cancer incidence rates are rising in 27 of 50 countries ...

Cloning is steadily becoming an important aspect of One Piece's world, but how exactly does this process work?

Recent viral mutations have shown avian influenza’s adaptability to mammalian hosts, prompting infectious disease, animal ...

Researchers at City of Hope have found that cell mutations are necessary but not always sufficient for tumors to form.

Researchers studying over 2,000 Ashkenazi Jewish centenarians uncovered two rare IGF-1 gene variants linked to exceptional ...

Targeted therapies have significantly improved outcomes for patients with non-small cell lung cancer (NSCLC) with actionable mutations. However, many tumors inevitably develop drug resistance and ...

Johnson & Johnson (NYSE: JNJ) has announced important overall survival (OS) results from the Phase III MARIPOSA study.

Compared to osimertinib, Rybrevant (amivantamab-vmjw) plus Lazcluze (lazertinib) significantly extended overall survival.